Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1124 | D-1553 Wiki | 0.71 |
| drug1737 | High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma Wiki | 0.71 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D009369 | Neoplasms, NIH | 0.12 |
| D011014 | Pneumonia NIH | 0.04 |
| D007239 | Infection NIH | 0.03 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0002664 | Neoplasm HPO | 0.12 |
| HP:0002090 | Pneumonia HPO | 0.04 |
Navigate: Correlations HPO
There are 2 clinical trials
The objectives of this study are to test the level of accuracy of the prediction models that could be used as a 'digital test' to evaluate whether an individual is infected with COVID-19, based on their symptoms reported in the "AiM COVID-19" app
Description: Self reported body temperature (Degrees Celsius)
Measure: Fever Time: 1 dayDescription: Self reported shortness of breath symptom (tick box)
Measure: Shortness of Breath Time: 1 dayDescription: Self reported cough symptom (tick box)
Measure: Cough Time: 1 dayDescription: Self reported soar throat symptom (tick box)
Measure: Sore Throat Time: 1 dayDescription: Self reported headache symptom (tick box)
Measure: Headache Time: 1 dayDescription: Self reported muscle/ joint pain symptom (tick box)
Measure: Muscle/ Joint Pain Time: 1 dayDescription: Self reported diarrhoea symptom (tick box)
Measure: Diarrhoea Time: 1 dayDescription: Self reported vomiting/ nausea symptom (tick box)
Measure: Vomiting/ Nausea Time: 1 dayDescription: Self reported runny nose symptom (tick box)
Measure: Runny Nose Time: 1 dayDescription: Self reported loss of smell/ taste symptom (tick box)
Measure: Loss of Smell/Taste Time: 1 dayDescription: Self reported other symptoms (tick box)
Measure: Other symptoms Time: 1 dayThis is a phase 1/2, open label study of D-1553 single agent and combination treatment to assess the safety and tolerability, identify the MTD and RP2D, evaluate the PK properties and antitumor activities in subjects with advanced or metastatic solid tumor with KRasG12C mutation.
Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports